AGEs, which accumulate with age and in metabolic diseases like diabetes, trigger pro-inflammatory signaling (e.g., NF-κB, MAPKs), leading to oxidative stress, cytokine release, and matrix metalloproteinase (MMP) activation. Here, NFKB1 is linked to metabolic disease.